Kumar Manoj, Nigam Vibhav, Kumar Sandeep, Pathak Anumesh K
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029 India.
Department of Biochemistry, Integral University, Lucknow, 226026 India.
J Diabetes Metab Disord. 2025 May 7;24(1):114. doi: 10.1007/s40200-025-01625-5. eCollection 2025 Jun.
To evaluate the effects of a very-low-calorie diet (VLCD) on insulin resistance (IR), metabolic gene expression, and fatty acid profiles in obese patients (body mass index [BMI] ≥ 30 kg/m) undergoing bariatric surgery compared to age- and sex-matched nonobese controls (BMI ≤ 25 kg/m) undergoing elective abdominal surgery.
A total of 38 participants (21 obese and 17 nonobese controls) were recruited for this study. Obese patients underwent VLCD (800 kcal/day) for four weeks before surgery. Fasting blood samples and tissue biopsies were collected during surgery. Key parameters included IR (measured using HOMA-IR), metabolic gene expression (quantified via RT-PCR), and fatty acid composition (analyzed by gas chromatography). Data were compared between pre- and post-VLCD groups in the obese cohort.
GLUT4 expression was reduced (1.57-fold, = 0.025), whereas PDK4 (3.9-fold, = 0.002), CPT1 (2.5-fold, = 0.013), and AMPK (twofold, = 0.004) expression were Correlation analysis revealed that GLUT4 was negatively correlated with BMI (r = -0.85), glucose (r = -0.94), and IR (r = -0.79), CPT1 was positively correlated with these parameters (BMI: r = 0.84, glucose: r = 0.92, IR: r = 0.82). VLCD significantly reduced monounsaturated fatty acids, including alpha-linolenic acid ( = 0.03) and erucic acid ( = 0.019). Postsurgical improvements included reductions in BMI (Δ = 6.21, < 0.0001), glucose level (Δ = 6.94, = 0.0007), and IR (Δ = 10.19, = 0.0039).
VLCD modulated metabolic gene expression and fatty acid profiles, enhancing IR and metabolic health both pre- and post-surgery. This represents a critical strategy for optimizing the outcomes of obese patients undergoing bariatric surgery.
The online version contains supplementary material available at 10.1007/s40200-025-01625-5.
评估极低热量饮食(VLCD)对接受减肥手术的肥胖患者(体重指数[BMI]≥30kg/m²)胰岛素抵抗(IR)、代谢基因表达和脂肪酸谱的影响,并与接受择期腹部手术的年龄和性别匹配的非肥胖对照组(BMI≤25kg/m²)进行比较。
本研究共招募了38名参与者(21名肥胖者和17名非肥胖对照组)。肥胖患者在手术前接受四周的VLCD(800千卡/天)。手术期间采集空腹血样和组织活检样本。关键参数包括IR(使用HOMA-IR测量)、代谢基因表达(通过RT-PCR定量)和脂肪酸组成(通过气相色谱分析)。对肥胖队列中VLCD前后组的数据进行比较。
GLUT4表达降低(1.57倍,P = 0.025),而PDK4(3.9倍,P = 0.002)、CPT1(2.5倍,P = 0.013)和AMPK(2倍,P = 0.004)表达升高。相关分析显示,GLUT4与BMI(r = -0.85)、葡萄糖(r = -0.94)和IR(r = -0.79)呈负相关,CPT1与这些参数呈正相关(BMI:r = 0.84,葡萄糖:r = 0.92,IR:r = 0.82)。VLCD显著降低了单不饱和脂肪酸,包括α-亚麻酸(P = 0.03)和芥酸(P = 0.019)。术后改善包括BMI降低(Δ = 6.21,P < 0.0001)、血糖水平降低(Δ = 6.94,P = 0.0007)和IR降低(Δ = 10.19,P = 0.0039)。
VLCD调节代谢基因表达和脂肪酸谱,在手术前后均增强了IR和代谢健康。这是优化接受减肥手术的肥胖患者手术效果的关键策略。
在线版本包含可在10.1007/s40200-025-01625-5获取的补充材料。